Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial - Wikidata - awgldk - TriplyDB

Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial

Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial

http://www.wikidata.org/entity/Q35730907

about

Microglia centered pathogenesis in ALS: insights in cell interconnectivity The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases Bile Acids in Neurodegenerative Disorders Amyotrophic lateral sclerosis and motor neuron syndromes in Asia.Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.Hydrophilic bile acids protect human blood-brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis ALSUntangled no. 25: ursodiol.Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration.Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis.High Dose and Delayed Treatment with Bile Acids Ineffective in RML Prion-Infected Mice

P2860

Q27009559-950EE92B-5BD3-4047-839E-4FEAB98D79ED Q27026087-D0CE30C6-97F7-4A2E-957A-B46F8FD2AF64 Q28078549-6182DB5A-BF2F-4F2C-8302-27C9EC4E7CE0 Q30251559-15003902-BBDA-425B-91B4-155C52F8A094 Q34401653-680735EF-2A3B-49C0-97A1-489F83B02FDB Q34436090-65A1F175-92ED-403A-8122-BE577469791D Q35172521-4F58DEB6-0E68-465F-9D9F-F3998ACD8C93 Q37257418-DB5A5D69-9F60-4043-BD56-9869354BA31C Q38223869-183A4968-44DB-4B89-A598-4243EF2B2CCB Q46891717-F51A1DB5-91CF-4BCB-BD8F-41B212CE71CA Q48116439-7D0B20B0-AAB7-4AF2-A0B2-A4454665D686 Q57113939-204421F2-75F6-41FB-9C80-FE0354D8E3F6

P2860

Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial

http://www.wikidata.org/entity/Q35730907

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Oral solubilized ursodeoxychol ...... a randomized cross-over trial

@ast

Oral solubilized ursodeoxychol ...... a randomized cross-over trial

@en

type

label

Oral solubilized ursodeoxychol ...... a randomized cross-over trial

@ast

Oral solubilized ursodeoxychol ...... a randomized cross-over trial

@en

prefLabel

Oral solubilized ursodeoxychol ...... a randomized cross-over trial

@ast

Oral solubilized ursodeoxychol ...... a randomized cross-over trial

@en

P1433

Q35730907-C80DD67E-18EF-41A8-AEEF-45D969D2623A

P1476

Q35730907-26FB1C8B-1672-4C07-A112-0B47746FBE66

P2093

Q35730907-5F6F393B-D794-4091-A1AA-2DDB2CDB78F6

Q35730907-6888E4C8-00F0-40B3-9646-D4428CC5DC2A

Q35730907-7447DC0E-2454-4492-BDA7-D85C2A8DA908

Q35730907-753980E8-0427-4322-A747-DBBC8000323B

Q35730907-923EEEFD-87CE-4576-A9FB-F699F49E627D

Q35730907-A5501E23-F8E1-4467-96FC-145E04659C7C

P2860

Q35730907-05B1848F-812B-462A-B820-884F17EFDDBE

Q35730907-21BA3721-FA4E-4EF1-96F9-5FB8680C455A

Q35730907-34988CC2-732C-4136-9A9E-CF70E3010C6C

Q35730907-4FB99267-5244-4E31-B0BB-BDC84895B0E9

Q35730907-52211AC6-274E-4F37-9025-AF3EEF806271

Q35730907-550115FA-9CA7-4B4E-88EB-43EE7282942F

Q35730907-55F10F54-30D7-4F72-9829-7E45609BB7C0

Q35730907-5B06905F-D060-449E-BE4A-F4BD0B32BA97

Q35730907-5B726AAD-44FA-4FF3-B404-E6E84F256AFF

Q35730907-65F5C0F3-AD78-44AD-A425-F15CA5D5D15A

P304

Q35730907-6C70CF7C-CB4D-4CC5-BD39-45FE3700B5A0

P31

Q35730907-E4B36EA4-4977-46B1-A02B-E585D9DF44BA

P356

Q35730907-94B373F3-74B6-4428-80AE-A851620D903F

P433

Q35730907-59175C4C-3D2F-4ECF-AD0B-1B82CFA6BCF7

P478

Q35730907-F2D0CBF2-39A6-4C1B-9662-B60B5D5584DA

P577

Q35730907-1816AECD-307C-42CE-B058-5B1C892D1777

P5875

Q35730907-021C3F2C-E054-418B-A3FD-4B484338AE05

P698

Q35730907-78EB3252-9286-46D9-8068-F3CFF71E1597

P921

Q35730907-A97995E1-B8D9-43DE-A591-35ED04538BB2

P932

Q35730907-C1C0282A-2D02-4794-B217-DBF8E756563B

P356

JKMS.2012.27.2.200

P1433

Journal of Korean Medical Science

P1476

Oral solubilized ursodeoxychol ...... a randomized cross-over trial

@en

P2093

Ju-Hong Min

http://www.w3.org/2001/XMLSchema#string

Jung Bok Lee

http://www.w3.org/2001/XMLSchema#string

Jung-Joon Sung

http://www.w3.org/2001/XMLSchema#string

Kwang-Woo Lee

http://www.w3.org/2001/XMLSchema#string

Sung-Min Kim

http://www.w3.org/2001/XMLSchema#string

Yoon-Ho Hong

http://www.w3.org/2001/XMLSchema#string

P2860

p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis

ALS: a disease of motor neurons and their nonneuronal neighbors

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis.

Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease.

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent.

Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway.

Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats

Immunomodulating and anti-apoptotic action of ursodeoxycholic acid: where are we and where should we go?

P304

200-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3346/JKMS.2012.27.2.200

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221822356

http://www.w3.org/2001/XMLSchema#string

P698

22323869

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

3271295

http://www.w3.org/2001/XMLSchema#string